Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Investigate common budgeting blockers that prevent savings and identify actionable changes. This intro guides you toward steady, growing savings.
27,247 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
This week, 180 leaders from business, government, nonprofits, academia, technology, and the arts converged for Brains...
Plug Power has captured attention as its revenue growth accelerates amid a reshaped hydrogen market. This article bre...
As investors seek clarity in a shifting media world, Newsmax’s Q1 2026 earnings offer clues about growth, profitabili...
CWB blends income with potential equity upside, but its behavior shifts from bond-like to stock-like in market downtu...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
Cerebras hit the market with fireworks, then cooled off quickly. This guide explains what happened, how to value the ...
Gold resumes its ascent in 2026, with three ETFs offering distinct risk paths to access the metal. GLD, GLDM, and GDX...
NVIDIA’s latest announcements are stirring chatter about AI-driven growth and new catalysts. Here’s what investors sh...
Over 10 years, Meta Platforms turned a $1,000 investment into about $5,300, but the decade-long test against the S&P ...
Bitcoin has shown dramatic swings, but understanding downside helps you invest smarter. This guide breaks down what '...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...